Ex-Pfizer CEO Ian Read in 2017 (Kristoffer Tripplaar/Sipa via AP Images)
October 9, 2024 11:28 PM EDTUpdated 07:42 AM
People
Pharma

For­mer Pfiz­er CEO and CFO flip on ac­tivist and say they now sup­port com­pa­ny

Drew Armstrong

Executive Editor

Max Bayer

Pharma Reporter

In a late-night re­ver­sal, Pfiz­er’s for­mer CEO and CFO is­sued a state­ment say­ing they now sup­port the com­pa­ny’s ex­ist­ing man­age­ment over ac­tivist in­vestor Star­board Val­ue …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times